Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Adipose Tissue, Brown | 10 | 2023 | 91 | 5.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 17 | 2022 | 182 | 3.650 |
Why?
|
Mechanistic Target of Rapamycin Complex 2 | 9 | 2020 | 17 | 3.270 |
Why?
|
Adipocytes | 14 | 2022 | 250 | 3.090 |
Why?
|
TOR Serine-Threonine Kinases | 19 | 2022 | 107 | 3.020 |
Why?
|
Adipose Tissue, White | 10 | 2022 | 82 | 2.810 |
Why?
|
Adipocytes, Brown | 8 | 2023 | 43 | 2.530 |
Why?
|
Adipogenesis | 9 | 2019 | 71 | 2.420 |
Why?
|
Lipogenesis | 7 | 2020 | 65 | 2.260 |
Why?
|
Obesity | 11 | 2023 | 1182 | 2.190 |
Why?
|
Glutamine | 2 | 2024 | 43 | 1.820 |
Why?
|
Multiprotein Complexes | 10 | 2016 | 147 | 1.720 |
Why?
|
Protein Kinases | 10 | 2009 | 137 | 1.710 |
Why?
|
Insulin | 9 | 2022 | 692 | 1.600 |
Why?
|
Rapamycin-Insensitive Companion of mTOR Protein | 9 | 2022 | 11 | 1.600 |
Why?
|
Signal Transduction | 26 | 2022 | 2830 | 1.420 |
Why?
|
Thermogenesis | 7 | 2023 | 99 | 1.390 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2022 | 668 | 1.350 |
Why?
|
Transcription Factors | 10 | 2017 | 1448 | 1.340 |
Why?
|
Animals | 47 | 2024 | 19175 | 1.210 |
Why?
|
Subcutaneous Fat | 2 | 2020 | 49 | 1.210 |
Why?
|
Carrier Proteins | 8 | 2020 | 707 | 1.200 |
Why?
|
Adipose Tissue | 6 | 2024 | 294 | 1.200 |
Why?
|
Glucose | 7 | 2023 | 438 | 1.160 |
Why?
|
Myogenic Regulatory Factor 5 | 4 | 2014 | 16 | 1.140 |
Why?
|
Neoplasms | 5 | 2023 | 1172 | 1.110 |
Why?
|
Mice | 31 | 2023 | 10019 | 1.090 |
Why?
|
Insulin Resistance | 7 | 2019 | 404 | 1.020 |
Why?
|
Mechanistic Target of Rapamycin Complex 1 | 9 | 2017 | 50 | 1.000 |
Why?
|
Cell Lineage | 8 | 2019 | 244 | 0.990 |
Why?
|
Nuclear Proteins | 5 | 2019 | 758 | 0.960 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 4 | 2019 | 34 | 0.930 |
Why?
|
PTEN Phosphohydrolase | 4 | 2012 | 78 | 0.920 |
Why?
|
Adipocytes, White | 2 | 2015 | 26 | 0.920 |
Why?
|
Metabolic Diseases | 1 | 2024 | 52 | 0.920 |
Why?
|
Lipid Metabolism | 4 | 2020 | 200 | 0.910 |
Why?
|
ATP Citrate (pro-S)-Lyase | 2 | 2020 | 12 | 0.880 |
Why?
|
Phosphatidylinositol 3-Kinases | 5 | 2012 | 160 | 0.870 |
Why?
|
Acetyl Coenzyme A | 1 | 2023 | 22 | 0.860 |
Why?
|
ADP-Ribosylation Factor 1 | 1 | 2022 | 5 | 0.850 |
Why?
|
Protein Interaction Maps | 1 | 2022 | 31 | 0.840 |
Why?
|
Cold Temperature | 2 | 2021 | 49 | 0.780 |
Why?
|
Isotope Labeling | 1 | 2021 | 68 | 0.780 |
Why?
|
Energy Metabolism | 5 | 2022 | 346 | 0.730 |
Why?
|
Forkhead Box Protein O1 | 2 | 2019 | 16 | 0.710 |
Why?
|
Cell Growth Processes | 2 | 2012 | 35 | 0.710 |
Why?
|
Second Messenger Systems | 1 | 2019 | 26 | 0.700 |
Why?
|
Cell Division | 5 | 2006 | 440 | 0.690 |
Why?
|
Sirtuins | 1 | 2019 | 24 | 0.680 |
Why?
|
Protein Kinase Inhibitors | 2 | 2012 | 158 | 0.680 |
Why?
|
Lipolysis | 1 | 2019 | 46 | 0.670 |
Why?
|
Muscle Development | 2 | 2019 | 52 | 0.660 |
Why?
|
Sirtuin 1 | 1 | 2018 | 22 | 0.650 |
Why?
|
Oncogenes | 1 | 2019 | 63 | 0.640 |
Why?
|
Gastrointestinal Transit | 1 | 2018 | 6 | 0.640 |
Why?
|
Phosphorylation | 10 | 2022 | 851 | 0.620 |
Why?
|
Sirolimus | 6 | 2012 | 67 | 0.610 |
Why?
|
Gene Knockout Techniques | 3 | 2020 | 87 | 0.600 |
Why?
|
Trans-Activators | 2 | 2012 | 295 | 0.590 |
Why?
|
Mice, Inbred C57BL | 10 | 2021 | 3092 | 0.590 |
Why?
|
Humans | 34 | 2024 | 57066 | 0.590 |
Why?
|
Prostatic Neoplasms | 2 | 2012 | 319 | 0.590 |
Why?
|
Lipodystrophy | 1 | 2017 | 11 | 0.580 |
Why?
|
Cell Cycle Proteins | 4 | 2004 | 372 | 0.540 |
Why?
|
Protein Subunits | 1 | 2016 | 160 | 0.520 |
Why?
|
Cell Differentiation | 5 | 2019 | 1279 | 0.520 |
Why?
|
Homologous Recombination | 1 | 2015 | 24 | 0.510 |
Why?
|
rab1 GTP-Binding Proteins | 1 | 2014 | 6 | 0.500 |
Why?
|
Integrases | 1 | 2015 | 35 | 0.490 |
Why?
|
Liver | 3 | 2016 | 749 | 0.490 |
Why?
|
Fatty Acids | 3 | 2021 | 187 | 0.480 |
Why?
|
Homeodomain Proteins | 1 | 2015 | 252 | 0.440 |
Why?
|
Schizosaccharomyces pombe Proteins | 3 | 2004 | 74 | 0.430 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2016 | 317 | 0.420 |
Why?
|
Schizosaccharomyces | 4 | 2004 | 106 | 0.420 |
Why?
|
Mice, Knockout | 7 | 2019 | 1951 | 0.410 |
Why?
|
Colorectal Neoplasms | 1 | 2014 | 248 | 0.400 |
Why?
|
Drosophila Proteins | 5 | 2011 | 675 | 0.400 |
Why?
|
Cell Survival | 1 | 2012 | 543 | 0.370 |
Why?
|
Protein Tyrosine Phosphatases | 2 | 2001 | 57 | 0.370 |
Why?
|
Autophagy | 1 | 2012 | 202 | 0.360 |
Why?
|
Fatty Acid Synthases | 2 | 2020 | 22 | 0.340 |
Why?
|
Muscle, Skeletal | 4 | 2023 | 651 | 0.330 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2006 | 29 | 0.330 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 47 | 0.320 |
Why?
|
Saccharomyces cerevisiae Proteins | 3 | 2004 | 419 | 0.320 |
Why?
|
Proteins | 9 | 2012 | 740 | 0.320 |
Why?
|
Protein Kinase C-alpha | 2 | 2006 | 16 | 0.300 |
Why?
|
HEK293 Cells | 2 | 2020 | 559 | 0.300 |
Why?
|
Forkhead Transcription Factors | 2 | 2011 | 115 | 0.300 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2006 | 7 | 0.290 |
Why?
|
Drosophila | 3 | 2006 | 412 | 0.280 |
Why?
|
Genes, Developmental | 1 | 2006 | 5 | 0.280 |
Why?
|
Male | 13 | 2023 | 26218 | 0.270 |
Why?
|
Gene Expression Regulation | 4 | 2017 | 1531 | 0.260 |
Why?
|
Metabolic Networks and Pathways | 2 | 2023 | 72 | 0.260 |
Why?
|
Models, Biological | 5 | 2016 | 1132 | 0.250 |
Why?
|
Spindle Apparatus | 2 | 2002 | 123 | 0.250 |
Why?
|
Gene Expression | 2 | 2020 | 798 | 0.240 |
Why?
|
PPAR gamma | 3 | 2020 | 70 | 0.240 |
Why?
|
Glycolysis | 2 | 2021 | 54 | 0.240 |
Why?
|
Disease Models, Animal | 4 | 2023 | 1996 | 0.230 |
Why?
|
Mice, Transgenic | 2 | 2019 | 1203 | 0.230 |
Why?
|
Mitosis | 2 | 2002 | 207 | 0.230 |
Why?
|
Body Fat Distribution | 2 | 2013 | 11 | 0.220 |
Why?
|
Genes, cdc | 1 | 2002 | 14 | 0.220 |
Why?
|
Adipokines | 1 | 2022 | 27 | 0.210 |
Why?
|
Genomics | 2 | 2024 | 305 | 0.210 |
Why?
|
RNA Interference | 6 | 2011 | 583 | 0.210 |
Why?
|
Protein Interaction Mapping | 1 | 2022 | 69 | 0.200 |
Why?
|
DNA Damage | 1 | 2024 | 278 | 0.200 |
Why?
|
Phosphatidylglycerols | 1 | 2021 | 10 | 0.200 |
Why?
|
Metabolomics | 1 | 2022 | 44 | 0.200 |
Why?
|
Citric Acid Cycle | 1 | 2021 | 20 | 0.200 |
Why?
|
Metabolome | 1 | 2021 | 22 | 0.200 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2012 | 191 | 0.190 |
Why?
|
Luminescent Proteins | 3 | 2012 | 128 | 0.190 |
Why?
|
Cells, Cultured | 5 | 2014 | 2081 | 0.190 |
Why?
|
Gene Targeting | 2 | 2015 | 82 | 0.190 |
Why?
|
Protein Binding | 5 | 2009 | 1542 | 0.190 |
Why?
|
Diet, High-Fat | 3 | 2019 | 153 | 0.190 |
Why?
|
Homeostasis | 3 | 2019 | 328 | 0.190 |
Why?
|
Adult | 4 | 2023 | 15129 | 0.180 |
Why?
|
Oxidation-Reduction | 1 | 2021 | 304 | 0.180 |
Why?
|
Amino Acids | 1 | 2021 | 141 | 0.180 |
Why?
|
Female | 9 | 2019 | 29606 | 0.180 |
Why?
|
Acetate-CoA Ligase | 1 | 2020 | 1 | 0.180 |
Why?
|
Transcriptome | 2 | 2021 | 304 | 0.180 |
Why?
|
Gene Expression Profiling | 4 | 2011 | 681 | 0.180 |
Why?
|
Response Elements | 1 | 2020 | 42 | 0.180 |
Why?
|
Glucose Transporter Type 4 | 1 | 2020 | 56 | 0.180 |
Why?
|
Neural Crest | 1 | 2019 | 27 | 0.170 |
Why?
|
HeLa Cells | 2 | 2019 | 526 | 0.170 |
Why?
|
Proteome | 1 | 2020 | 131 | 0.170 |
Why?
|
Protein Methyltransferases | 1 | 2019 | 14 | 0.170 |
Why?
|
Neural Stem Cells | 1 | 2019 | 42 | 0.160 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2019 | 32 | 0.160 |
Why?
|
Dietary Carbohydrates | 1 | 2019 | 79 | 0.160 |
Why?
|
Tumor Suppressor Proteins | 2 | 2012 | 182 | 0.160 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2018 | 13 | 0.160 |
Why?
|
Methylation | 1 | 2019 | 122 | 0.160 |
Why?
|
Neurogenesis | 1 | 2019 | 59 | 0.160 |
Why?
|
Stromal Cells | 1 | 2018 | 65 | 0.150 |
Why?
|
Proteomics | 1 | 2020 | 239 | 0.150 |
Why?
|
Uncoupling Protein 1 | 1 | 2017 | 44 | 0.150 |
Why?
|
Carcinogenesis | 1 | 2019 | 113 | 0.150 |
Why?
|
Gene Deletion | 2 | 2016 | 297 | 0.150 |
Why?
|
Adaptor Proteins, Signal Transducing | 4 | 2013 | 410 | 0.140 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 343 | 0.140 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2017 | 191 | 0.140 |
Why?
|
Histones | 1 | 2020 | 460 | 0.140 |
Why?
|
Mutation | 4 | 2006 | 2385 | 0.130 |
Why?
|
Tuberculosis | 1 | 2019 | 250 | 0.130 |
Why?
|
Receptors, Immunologic | 1 | 2017 | 176 | 0.130 |
Why?
|
Gene Editing | 1 | 2020 | 275 | 0.130 |
Why?
|
Protein Structure, Tertiary | 4 | 2015 | 663 | 0.130 |
Why?
|
Organ Specificity | 1 | 2016 | 178 | 0.130 |
Why?
|
Flow Cytometry | 2 | 2012 | 657 | 0.130 |
Why?
|
Inflammation | 2 | 2019 | 1066 | 0.130 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2019 | 626 | 0.130 |
Why?
|
Cytoskeleton | 2 | 2006 | 139 | 0.120 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 2 | 2011 | 23 | 0.120 |
Why?
|
Up-Regulation | 2 | 2006 | 357 | 0.120 |
Why?
|
Bone Morphogenetic Protein 7 | 1 | 2014 | 15 | 0.120 |
Why?
|
MyoD Protein | 1 | 2014 | 42 | 0.120 |
Why?
|
Receptor, Insulin | 1 | 2014 | 46 | 0.120 |
Why?
|
Stem Cells | 1 | 2016 | 247 | 0.120 |
Why?
|
Cell Proliferation | 3 | 2013 | 922 | 0.110 |
Why?
|
Th2 Cells | 1 | 2013 | 97 | 0.110 |
Why?
|
Proto-Oncogene Proteins | 2 | 2005 | 313 | 0.110 |
Why?
|
Diet | 1 | 2017 | 646 | 0.110 |
Why?
|
Receptors, Adrenergic, beta-3 | 1 | 2012 | 6 | 0.110 |
Why?
|
Lipomatosis | 1 | 2012 | 8 | 0.110 |
Why?
|
Histological Techniques | 1 | 2012 | 18 | 0.110 |
Why?
|
Receptors, Cell Surface | 1 | 2015 | 437 | 0.110 |
Why?
|
Leukemia | 1 | 2012 | 53 | 0.100 |
Why?
|
Hematopoiesis | 1 | 2012 | 120 | 0.100 |
Why?
|
Muscle Cells | 1 | 2011 | 26 | 0.100 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2012 | 187 | 0.100 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2011 | 6 | 0.100 |
Why?
|
Cell Separation | 1 | 2011 | 145 | 0.100 |
Why?
|
Sarcoma | 1 | 2011 | 54 | 0.100 |
Why?
|
Ribosomal Protein S6 | 1 | 2011 | 1 | 0.100 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 517 | 0.100 |
Why?
|
Longevity | 1 | 2012 | 108 | 0.100 |
Why?
|
Drug Discovery | 1 | 2012 | 83 | 0.090 |
Why?
|
Membrane Proteins | 1 | 2017 | 832 | 0.090 |
Why?
|
Lymphocyte Activation | 1 | 2013 | 731 | 0.090 |
Why?
|
Antineoplastic Agents | 2 | 2024 | 625 | 0.090 |
Why?
|
Adenosine Triphosphate | 1 | 2012 | 282 | 0.090 |
Why?
|
Regulatory-Associated Protein of mTOR | 4 | 2013 | 7 | 0.090 |
Why?
|
Tacrolimus Binding Protein 1A | 1 | 2009 | 2 | 0.080 |
Why?
|
Everolimus | 1 | 2009 | 16 | 0.080 |
Why?
|
Microarray Analysis | 2 | 2011 | 55 | 0.080 |
Why?
|
Cell Line | 3 | 2015 | 2001 | 0.080 |
Why?
|
Green Fluorescent Proteins | 2 | 2001 | 351 | 0.080 |
Why?
|
T-Lymphocytes | 1 | 2013 | 944 | 0.080 |
Why?
|
Mice, Obese | 2 | 2019 | 74 | 0.080 |
Why?
|
Fluorescent Antibody Technique | 3 | 2011 | 219 | 0.080 |
Why?
|
Prostate | 1 | 2009 | 52 | 0.080 |
Why?
|
Neoplasm Transplantation | 1 | 2009 | 157 | 0.080 |
Why?
|
Recombinant Proteins | 1 | 2011 | 685 | 0.080 |
Why?
|
Mice, Nude | 1 | 2009 | 256 | 0.080 |
Why?
|
Transplantation, Heterologous | 1 | 2009 | 222 | 0.080 |
Why?
|
Aged, 80 and over | 1 | 2017 | 4814 | 0.080 |
Why?
|
Phenotype | 2 | 2009 | 1097 | 0.080 |
Why?
|
Young Adult | 1 | 2017 | 4130 | 0.080 |
Why?
|
3T3 Cells | 2 | 2018 | 107 | 0.070 |
Why?
|
Drosophila melanogaster | 3 | 2011 | 473 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2009 | 279 | 0.070 |
Why?
|
Fibroblasts | 1 | 2009 | 346 | 0.070 |
Why?
|
Middle Aged | 3 | 2019 | 15410 | 0.070 |
Why?
|
Forkhead Box Protein O3 | 1 | 2006 | 8 | 0.070 |
Why?
|
Fetal Viability | 1 | 2006 | 3 | 0.070 |
Why?
|
Glycogen Synthase Kinase 3 beta | 1 | 2006 | 24 | 0.070 |
Why?
|
Mice, Inbred BALB C | 1 | 2009 | 875 | 0.070 |
Why?
|
Fetal Development | 1 | 2006 | 18 | 0.070 |
Why?
|
Bacterial Proteins | 1 | 2012 | 732 | 0.070 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2006 | 39 | 0.070 |
Why?
|
Epithelial Cells | 1 | 2009 | 361 | 0.070 |
Why?
|
Cell Enlargement | 1 | 2006 | 9 | 0.070 |
Why?
|
Embryo, Mammalian | 1 | 2006 | 163 | 0.070 |
Why?
|
Precipitin Tests | 2 | 2004 | 79 | 0.060 |
Why?
|
Genes, Tumor Suppressor | 1 | 2005 | 73 | 0.060 |
Why?
|
Down-Regulation | 1 | 2006 | 299 | 0.060 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 2004 | 179 | 0.060 |
Why?
|
Immunoblotting | 2 | 2004 | 188 | 0.060 |
Why?
|
Blotting, Western | 2 | 2011 | 585 | 0.060 |
Why?
|
Cell Cycle | 3 | 2013 | 377 | 0.060 |
Why?
|
Transcription, Genetic | 2 | 2015 | 845 | 0.060 |
Why?
|
Ribosomes | 1 | 2006 | 155 | 0.060 |
Why?
|
Amino Acid Sequence | 3 | 2004 | 1568 | 0.060 |
Why?
|
Molecular Sequence Data | 3 | 2004 | 1968 | 0.060 |
Why?
|
Cell Line, Tumor | 2 | 2024 | 1320 | 0.060 |
Why?
|
Adrenergic Agents | 1 | 2022 | 16 | 0.050 |
Why?
|
Phosphoproteins | 1 | 2004 | 214 | 0.050 |
Why?
|
Cell Death | 1 | 2024 | 264 | 0.050 |
Why?
|
Plant Cells | 1 | 2002 | 11 | 0.050 |
Why?
|
Actomyosin | 1 | 2002 | 20 | 0.050 |
Why?
|
Aged | 1 | 2017 | 12583 | 0.050 |
Why?
|
Microtubule-Associated Proteins | 1 | 2002 | 109 | 0.050 |
Why?
|
Yeasts | 1 | 2002 | 51 | 0.050 |
Why?
|
Carbon Isotopes | 1 | 2022 | 16 | 0.050 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2002 | 42 | 0.050 |
Why?
|
Eukaryotic Cells | 1 | 2002 | 57 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2024 | 292 | 0.050 |
Why?
|
Phosphotransferases | 1 | 2001 | 21 | 0.050 |
Why?
|
Microtubules | 1 | 2002 | 210 | 0.050 |
Why?
|
RNA | 1 | 2004 | 398 | 0.050 |
Why?
|
Catalysis | 1 | 2001 | 149 | 0.050 |
Why?
|
Plasmids | 1 | 2001 | 273 | 0.050 |
Why?
|
Catalytic Domain | 1 | 2001 | 182 | 0.050 |
Why?
|
Mass Spectrometry | 1 | 2022 | 280 | 0.050 |
Why?
|
Gene Ontology | 1 | 2020 | 37 | 0.040 |
Why?
|
Structure-Activity Relationship | 1 | 2001 | 368 | 0.040 |
Why?
|
Temperature | 1 | 2001 | 296 | 0.040 |
Why?
|
Tubulin | 1 | 2000 | 73 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2020 | 119 | 0.040 |
Why?
|
Mutagenesis | 1 | 2000 | 131 | 0.040 |
Why?
|
Alleles | 1 | 2001 | 423 | 0.040 |
Why?
|
Microscopy, Fluorescence | 1 | 2001 | 392 | 0.040 |
Why?
|
Neural Tube | 1 | 2019 | 11 | 0.040 |
Why?
|
Twist-Related Protein 1 | 1 | 2019 | 12 | 0.040 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2000 | 357 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 1 | 2001 | 499 | 0.040 |
Why?
|
Tandem Mass Spectrometry | 1 | 2020 | 133 | 0.040 |
Why?
|
Cloning, Molecular | 1 | 2000 | 379 | 0.040 |
Why?
|
Acetylation | 1 | 2019 | 110 | 0.040 |
Why?
|
Carnitine O-Acetyltransferase | 1 | 2018 | 1 | 0.040 |
Why?
|
Protein Biosynthesis | 1 | 2001 | 295 | 0.040 |
Why?
|
Single-Cell Analysis | 1 | 2019 | 80 | 0.040 |
Why?
|
Neuroglia | 1 | 2019 | 76 | 0.040 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 120 | 0.040 |
Why?
|
Mice, Mutant Strains | 1 | 2019 | 302 | 0.040 |
Why?
|
Apoptosis | 1 | 2024 | 1017 | 0.040 |
Why?
|
Lentivirus | 1 | 2018 | 53 | 0.040 |
Why?
|
Cytosol | 1 | 2018 | 165 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2004 | 1130 | 0.040 |
Why?
|
Hypoxia | 1 | 2018 | 97 | 0.040 |
Why?
|
RNA, Small Interfering | 2 | 2018 | 838 | 0.040 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2016 | 22 | 0.040 |
Why?
|
3T3-L1 Cells | 1 | 2017 | 83 | 0.040 |
Why?
|
Mitochondria | 1 | 2020 | 323 | 0.040 |
Why?
|
NIH 3T3 Cells | 1 | 2017 | 94 | 0.040 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2017 | 62 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2019 | 420 | 0.030 |
Why?
|
Ubiquitination | 1 | 2016 | 103 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2017 | 189 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 2017 | 100 | 0.030 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 1 | 2015 | 13 | 0.030 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2015 | 21 | 0.030 |
Why?
|
RNA Polymerase II | 1 | 2015 | 72 | 0.030 |
Why?
|
Mycobacterium tuberculosis | 1 | 2019 | 372 | 0.030 |
Why?
|
CRISPR-Cas Systems | 1 | 2018 | 304 | 0.030 |
Why?
|
Enzyme Activation | 2 | 2005 | 351 | 0.030 |
Why?
|
Neurons | 1 | 2019 | 841 | 0.030 |
Why?
|
Sequence Alignment | 2 | 2004 | 289 | 0.030 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2012 | 12 | 0.030 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2012 | 45 | 0.030 |
Why?
|
Time Factors | 1 | 2000 | 3457 | 0.030 |
Why?
|
Gluconeogenesis | 1 | 2012 | 15 | 0.030 |
Why?
|
Glucose Clamp Technique | 1 | 2012 | 66 | 0.030 |
Why?
|
Muscle Neoplasms | 1 | 2011 | 7 | 0.030 |
Why?
|
Aurothioglucose | 1 | 2011 | 2 | 0.030 |
Why?
|
Hepatocyte Nuclear Factor 3-beta | 1 | 2011 | 5 | 0.030 |
Why?
|
Biomarkers | 1 | 2017 | 1127 | 0.020 |
Why?
|
Phosphatidate Phosphatase | 1 | 2011 | 1 | 0.020 |
Why?
|
ras Proteins | 1 | 2011 | 77 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2012 | 252 | 0.020 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2011 | 81 | 0.020 |
Why?
|
Survival Analysis | 1 | 2012 | 536 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2011 | 115 | 0.020 |
Why?
|
Chromatin | 1 | 2015 | 585 | 0.020 |
Why?
|
Triglycerides | 1 | 2011 | 246 | 0.020 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2012 | 304 | 0.020 |
Why?
|
Cytokines | 1 | 2013 | 888 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2011 | 136 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2011 | 834 | 0.020 |
Why?
|
Antirheumatic Agents | 1 | 2011 | 209 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2011 | 470 | 0.020 |
Why?
|
Genome | 1 | 2011 | 249 | 0.020 |
Why?
|
Biomarkers, Tumor | 1 | 2011 | 442 | 0.020 |
Why?
|
Rats | 1 | 2011 | 1880 | 0.020 |
Why?
|
Models, Genetic | 1 | 2006 | 253 | 0.020 |
Why?
|
3-Phosphoinositide-Dependent Protein Kinases | 1 | 2005 | 4 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2005 | 114 | 0.020 |
Why?
|
Serine | 1 | 2005 | 80 | 0.020 |
Why?
|
Gene Components | 1 | 2004 | 5 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2006 | 797 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2004 | 73 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2004 | 98 | 0.010 |
Why?
|
Conserved Sequence | 1 | 2004 | 170 | 0.010 |
Why?
|
DNA Primers | 1 | 2004 | 294 | 0.010 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2005 | 240 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2004 | 159 | 0.010 |
Why?
|
Software | 1 | 2006 | 351 | 0.010 |
Why?
|
Genetic Testing | 1 | 2004 | 129 | 0.010 |
Why?
|
Equipment Design | 1 | 2004 | 302 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2006 | 599 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2004 | 384 | 0.010 |
Why?
|
Actins | 1 | 2004 | 250 | 0.010 |
Why?
|
Transfection | 1 | 2004 | 665 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2006 | 1485 | 0.010 |
Why?
|